Cargando…

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis

We conducted one of the first prospective studies to test the hypothesis that the clinical history of priapism underestimates priapism incidence compared with a priapism pain diary. Eligibility criteria were men with sickle cell anemia (SCA) between 18 and 40 years of age who have had at least 3 epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Idris, Ibrahim M., Abba, Akib, Galadanci, Jamil A., Aji, Sani A., Jibrilla, Atiku U., Rodeghier, Mark, Kassim, Adetola, Burnett, Arthur L., DeBaun, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582584/
https://www.ncbi.nlm.nih.gov/pubmed/35816639
http://dx.doi.org/10.1182/bloodadvances.2022007285
_version_ 1784812872173355008
author Idris, Ibrahim M.
Abba, Akib
Galadanci, Jamil A.
Aji, Sani A.
Jibrilla, Atiku U.
Rodeghier, Mark
Kassim, Adetola
Burnett, Arthur L.
DeBaun, Michael R.
author_facet Idris, Ibrahim M.
Abba, Akib
Galadanci, Jamil A.
Aji, Sani A.
Jibrilla, Atiku U.
Rodeghier, Mark
Kassim, Adetola
Burnett, Arthur L.
DeBaun, Michael R.
author_sort Idris, Ibrahim M.
collection PubMed
description We conducted one of the first prospective studies to test the hypothesis that the clinical history of priapism underestimates priapism incidence compared with a priapism pain diary. Eligibility criteria were men with sickle cell anemia (SCA) between 18 and 40 years of age who have had at least 3 episodes of priapism in the past 12 months. Seventy-one men with SCA completed the diary for at least 3 months. The first 3 months of the priapism diary were included in the analysis. A total of 298 priapism episodes were recorded, and 80% (57 of 71) of the participants had at least 1 priapism event. Priapism severity was reported in the range of moderate to the worst imaginable pain in 81.5% (263 of 298), and a total 57 participants (80%) had a median pain rating of 6 (interquartile range: 5-8) on a scale from 1 to 10. The monthly incidence rate of priapism per participant based on history versus self-report pain diary was 2.0 (95% confidence interval, 1.9-2.1) and 1.4 (95% confidence interval, 1.2-1.6), respectively (P < .001). For participants that had a prior priapism episode, 80% had another episode during the 3-month interval follow-up. The median time to that second episode was 27.5 days. Major priapism occurred in 9.9% of episodes and was associated with the sum of all prospective priapism events. Men with SCA and at least 3 priapism episodes in the past 12 months are at significant risk for recurrent priapism in the following 3 months.
format Online
Article
Text
id pubmed-9582584
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-95825842022-10-28 Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis Idris, Ibrahim M. Abba, Akib Galadanci, Jamil A. Aji, Sani A. Jibrilla, Atiku U. Rodeghier, Mark Kassim, Adetola Burnett, Arthur L. DeBaun, Michael R. Blood Adv Regular Article We conducted one of the first prospective studies to test the hypothesis that the clinical history of priapism underestimates priapism incidence compared with a priapism pain diary. Eligibility criteria were men with sickle cell anemia (SCA) between 18 and 40 years of age who have had at least 3 episodes of priapism in the past 12 months. Seventy-one men with SCA completed the diary for at least 3 months. The first 3 months of the priapism diary were included in the analysis. A total of 298 priapism episodes were recorded, and 80% (57 of 71) of the participants had at least 1 priapism event. Priapism severity was reported in the range of moderate to the worst imaginable pain in 81.5% (263 of 298), and a total 57 participants (80%) had a median pain rating of 6 (interquartile range: 5-8) on a scale from 1 to 10. The monthly incidence rate of priapism per participant based on history versus self-report pain diary was 2.0 (95% confidence interval, 1.9-2.1) and 1.4 (95% confidence interval, 1.2-1.6), respectively (P < .001). For participants that had a prior priapism episode, 80% had another episode during the 3-month interval follow-up. The median time to that second episode was 27.5 days. Major priapism occurred in 9.9% of episodes and was associated with the sum of all prospective priapism events. Men with SCA and at least 3 priapism episodes in the past 12 months are at significant risk for recurrent priapism in the following 3 months. The American Society of Hematology 2022-07-14 /pmc/articles/PMC9582584/ /pubmed/35816639 http://dx.doi.org/10.1182/bloodadvances.2022007285 Text en © 2022 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Idris, Ibrahim M.
Abba, Akib
Galadanci, Jamil A.
Aji, Sani A.
Jibrilla, Atiku U.
Rodeghier, Mark
Kassim, Adetola
Burnett, Arthur L.
DeBaun, Michael R.
Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title_full Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title_fullStr Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title_full_unstemmed Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title_short Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
title_sort incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582584/
https://www.ncbi.nlm.nih.gov/pubmed/35816639
http://dx.doi.org/10.1182/bloodadvances.2022007285
work_keys_str_mv AT idrisibrahimm incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT abbaakib incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT galadancijamila incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT ajisania incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT jibrillaatikuu incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT rodeghiermark incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT kassimadetola incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT burnettarthurl incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis
AT debaunmichaelr incidenceandpredictorsofpriapismeventsinsicklecellanemiaadiarybasedanalysis